Skip to content

COMPARISON OF EFFECTIVENESS OF CONTINUOUS DRUG ADMINISTRATION AND INTERMITTENT INJECTIONS IN PARAVERTEBRAL SPACE IN CHEST IN PATIENTS WITH RIB FRACTURES

COMPARISON OF EFFICACY OF THORACIC PARAVERTEBRAL BLOCK USING CONTINUOUS INFUSION VERSUS INTERMITTENT BOLUSES OF ROPIVACAINE IN UNILATERAL MULTIPLE FRACTURED RIBS - A RANDOMIZED PILOT STUDY

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/11/016477
Enrollment
30
Registered
2018-11-30
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S224- Multiple fractures of ribs

Interventions

Intervention1: Intermittent Group: Ropivacaine 0.5% 0.3 mL/kg 6-hourly Control Intervention1: Continuous Infusion Group: Ropivacaine 0.5% 0.3 mL/kg bolus followed by continuous infusion of ropivacain

Sponsors

University College of Medical Sciences and GTB Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having 3 or more unilateral fractured ribs

Exclusion criteria

Exclusion criteria: 1. Unconscious patients 2. Patients with unstable cardiac status or severely altered mental status 3. Known liver/kidney disease 4. Known allergy to local anaesthetic drugs 5. Infection at site of needle insertion �Pre-existing spinal deformity �Patients having significant trauma outside chest wall, e.g. acute spine or pelvic fracture, severe traumatic brain or spinal cord injury or abdominal visceral injuries

Design outcomes

Secondary

MeasureTime frame
�VAS pain scores at rest and on coughing �Pulmonary function �Side effects, if any. Timepoint: 72 hours

Primary

MeasureTime frame
�Total morphine requirementsTimepoint: 72 hours

Countries

India

Contacts

Public ContactDr Shiv Kumar Sharma

University College of Medical Sciences and GTB Hospital

medhamohta@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026